BioCryst Pharma (NASDAQ: ) just reported results for the first quarter of 2024. InvestorPlace Earnings is a project that leverages data from TradeSmith to…
Monday, BioCryst Pharmaceuticals Inc BCRX reported a first-quarter earnings loss of $(0.17) per share versus the consensus estimate loss of $(0.21) per share…
BioCryst Pharma (BCRX) Files Mixed Shelf streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.